Published Paper Details:

In December 2019, a novel coronavirus named as SARS-CoV-2 caused a sequence of acute atypical respiratory diseases. The virus initiated in bats and was transferred to humans through yet unknown intermediate animals in Wuhan, Hubei Province, China 2019. The disease caused by this virus was named COVID-19. The symptoms related with this illness are cough, fever, running nose, mostly the respiratory issues. The peculiar thing is there is no accessible treatment or vaccine to treat this disease. There are only protective measures that can stop or control this virus spread. In March 2020, the World Health Organization (WHO) declared the COVID-19 outbreak a pandemic, including the U.S. Centers for Disease Control and Prevention (CDC) are monitoring the pandemic and posting updates on their websites. WHO launched the "Solidarity� is an international clinical trial to help find an effective treatment for COVID-19. Clinical trials and investigations to find out more about the virus, its origin, how it affects humans, and its management are ongoing. Several antiviral agents have been explored as possible therapeutic options to address the COVID-19 pandemic. Epidemiological studies showed that older patients were more vulnerable to severe diseases, however childrens tend to possess milder symptoms. Here we reviewed the updated knowledge about this syndrome and measured the possible description of the different symptomatology among childrens and adults. There have been nearby 96,000 described cases of corona virus disease 2019 (COVID-19) and 3300 described deaths to date (05/03/2020).